This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Stock Futures Pare Gains as Stein Hints at Tapering

NEW YORK ( TheStreet) -- Stock futures were paring gains Friday after Federal Reserve Governor Jeremy Stein indicated the Fed could begin curbing its bond-buying program in September, and BlackBerry (BBRY - Get Report) plunged after a disappointing quarter.

Futures for the S&P 500 were up 2 points, or 1.8 points above fair value, to 1,608.5. Futures for the Dow Jones Industrial Average were up 13 points, or 5.51 points above fair value, to 14,949. Futures for the Nasdaq were adding 2.75 points, or 2.66 points above fair value, to 2,902.25.

The benchmark 10-year Treasury was falling 8/32, boosting the yield to 2.502%. The dollar was down 0.05% to $82.86 according to the U.S. dollar index .

BlackBerry shares were plunging 23.41% to $11.09 after the company missed Wall Street's top- and bottom-line estimates in its first-quarter results on Friday. The smartphone maker reported revenue of $3.1 billion, up from $2.8 billion in the prior year's quarter, but below analysts' forecasts of $3.36 billion. BlackBerry reported a loss from continuing operations of $84 million, or 16 cents a share, compared with a loss of $510 million, or 97 cents a share, in the prior year's quarter.

Accenture (ACN - Get Report) was plunging more than 8% to $73.10 after the company's quarterly revenues missed expectations and the consulting firm reduced its full-year sales guidance after two years of growth.

During a speech on monetary policy to the Council on Foreign Relations in New York, Stein urged investors to not look so much nonfarm payrolls data that is released going into the month's meeting. He cautioned that any move by the central bank to wind down stimulus will likely be decided according to economic numbers that preceded those jobs numbers and had been released since the Fall 2012 period when QE3 was launched, in assessing the overall U.S. recovery and in order to lessen potential volatility in the markets.

"The best approach is for the Federal Reserve to be clear that in making a decision in, say, September, it will give primary weight to the large stock of news that has accumulated since the inception of the program and will not be unduly influenced by whatever data releases arrive in the few weeks before the meeting ... as salient as these releases may appear to be to market participants," Stein commented.

"Even if a data release from early September does not exert a strong influence on the decision to make an adjustment at the September meeting, that release will remain relevant for future decisions," he said. "If the news is bad, and it is confirmed by further bad news in October and November, this would suggest that the 7% unemployment goal is likely to be further away, and the remainder of the program would be extended accordingly."

More Fed speeches are expected Friday.

At 9:15 a.m., Richmond Fed President Jeffrey Lacker is scheduled to give a speech on economic outlook in White Sulphur Springs, West Virginia.

This will be followed by a speech from San Francisco Fed Bank President John Williams at 3:30 p.m.; his talk will focus on the economy and be delivered to the Sonoma Economic Conference in Rohnert Park, Calif.

In other corporate headlines, Pfizer (PFE - Get Report) was rising more than 1% to $28.50 after the drug maker unveiled a new $10 billion share repurchase program, adding to the $3.9 billion left over from its previous buyback plan.

Celgene (CELG - Get Report) has made a move to solidify its future in the multiple myeloma space, inking a licensing deal with Germany's MorphoSys AG for its MOR202 drug that could be worth $818 million to MorphoSys. Munich-based MorphoSys gets an up-front license fee of 70.8 million Euros ($92 million) and Celgene will purchase $60 million worth of new shares of the company, the parties said Thursday.

At 9:45 a.m. EDT, the Chicago Purchasing Managers Index is expected to show a decline to 56 in June from 58.7 in May.

The final estimate on the University of Michigan Consumer Sentiment Index will be released at 9:55 a.m. It's predicted to show come in at 82.7 for June, the same as the previous estimate.

The Hong Kong Hang Seng closed ahead by 1.78%. China's central bank chief Zhou Xiaochuan said Friday the it will continue to carry out "prudent" monetary policies, but will make tweaks and implement preemptive adjustments when needed and as appropriate.

The Nikkei 225 in Japan finished up 3.51% Friday. Japan's aggressive stimulus program, also commonly referred to as "Abenomics," appeared to have led to improving conditions there, as a spate of economic data Friday pointed to strengthening in the world's third-largest economy. Reports out Friday included retail sales, industrial output and inflation.

The FTSE 100 in London was up 0.06% and the DAX in Germany was down 0.15%.

August gold futures were tumbling $13.60 to $1,198 an ounce. August crude oil futures were rising 13 cents to $97.18 a barrel.

Written by Andrea Tse in New York

>To contact the writer of this article, click here: Andrea Tse.>.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
ACN $90.89 0.96%
BBRY $11.12 2.90%
CELG $120.55 -0.81%
PFE $34.67 1.00%
AAPL $128.63 0.13%

Markets

DOW 18,242.32 +109.62 0.60%
S&P 500 2,112.34 +7.84 0.37%
NASDAQ 4,994.0620 +30.5350 0.62%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs